Topic: Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cancer patients undergoing treatment with curative or palliative intent within the following treatment groups and corresponding cancer sites: 1.1. Chemotherapy: breast, ovarian, bladder, colorectal, leukaemia 1.2. Targeted agents (tyrosine kinase inhibitors, monoclonal antibodies): renal, myeloma, lymphoma, leukaemia, advanced breast cancer 1.3. Hormonotherapy: breast, prostate 1.4. Radiotherapy or chemoradiotherapy: prostate, lung, head and neck, oesophageal, rectal 1.5. Surgery: oesophageal, gastric, pancreas, liver resections, colorectal, lung 2. Patients receiving chemotherapy must be within their first two cycles of treatment 3. Patients receiving radiotherapy must be at the beginning of their treatment 4. Patients scheduled for surgery or within 1 month of discharge postsurgery 5. Able and willing to give informed consent 6. Able to read and understand English 7. Access to a touch tone telephone and/or computer with internet 8. Aged 18 years or over Target Gender: Male & Female ; Lower Age Limit 18 no age limit or unit specified
Exclusion criteria
Exclusion criteria: 1. Patients under the age of 18 2. Patients with overt exhibition of psychopathology or serious cognitive dysfunction which would impede study participation 3. Patients taking part in another clinical trial where there is a requirement to complete extensive quality of life questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Number of patients potentially eligible, number recruited and reasons for non-recruitment; Timepoint(s): End of study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of and timing of participant withdrawals from follow-up data collection and reasons for withdrawal; Timepoint(s): End of study 2. Proportion of expected weekly AE reports completed; Timepoint(s): End of study | — |
Countries
England, United Kingdom